International journal of epidemiology
Authors: Leng Y, Goldman SM, Cawthon PM, Stone KL, Ancoli-Israel S, Yaffe K
The American journal of cardiology
Authors: Lee TC, Qian M, Lip GYH, Di Tullio MR, Graham S, Mann DL, Nakanishi K, Teerlink JR, Freudenberger RS, Sacco RL, Mohr JP, Labovitz AJ, Ponikowski P, Lok DJ, Estol C, Anker SD, Pullicino PM, Buchsbaum R, Levin B, Thompson JLP, Homma S, Ye S
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Authors: Fitzpatrick J, Sozio SM, Jaar BG, Estrella MM, Segev DL, Parekh RS, McAdams-DeMarco MA
Health services research | Volume 53 of Issue 5
Authors: Yoon J, Chee CP, Su P, Almenoff P, Zulman DM, Wagner TH
OBJECTIVES
To examine high-cost patients in VA and factors associated with persistence in high costs over time.
DATA SOURCES
Secondary data for FY2008-2012.
DATA EXTRACTION
We obtained VA and Medicare utilization and cost records for VA enrollees and drew a 20 percent random sample (N = 1,028,568).
STUDY DESIGN
We identified high-cost patients, defined as those in the top 10 percent of combined VA and Medicare costs, and determined the number of years they remained high cost over 4 years. We compared sociodemographics, clinical characteristics, and baseline utilization by number of high-cost years and conducted a discrete time survival analysis to predict high-cost persistence.
PRINCIPAL FINDINGS
Among 105,703 patients with the highest 10 percent of costs at baseline, 68 percent did not remain high cost in subsequent years, 32 percent had high costs after 1 year, and 7 percent had high costs in all four follow-up years. Mortality, which was 47 percent by end of follow-up, largely explained low persistence. The largest percentage of patients who persisted as high cost until end of follow-up was for spinal cord injury (16 percent).
CONCLUSION
Most high-cost patients did not remain high cost in subsequent years, which poses challenges to providers and payers to manage utilization of these patients.
View on PubMed
Annals of the rheumatic diseases
Authors: L.S. Gensler, M. Gianfrancesco, M.H. Weisman, M.A. Brown, M. Lee, T. Learch, M. Rahbar, J.D. Reveille, M.M. Ward
Annals of the rheumatic diseases
Authors: D. van der Heijde, L.S. Gensler, A. Deodhar, X. Baraliakos, D. Poddubnyy, M.K. Farmer, D. Baeten, T. Kumke, M. Oortgiesen, M. Dougados
Genetics in medicine : official journal of the American College of Medical Genetics
Authors: Vassy JL, Stone A, Callaghan JT, Mendes M, Meyer LJ, Pratt VM, Przygodzki RM, Scheuner MT, Wang-Rodriguez J, Schichman SA, VHA Clinical Pharmacogenetics Subcommittee
Annals of the rheumatic diseases
Authors: A. Moltó, L. Gensler, M.E.B. Clowse, H. Marzo-Ortega, A. Artignan, D. Goff-Leggett, S. Leonard, H.K. Resemann, E. Thurtle, N. de Peyrecave, C. Ecoffet, F. Förger
Annals of the rheumatic diseases
Authors: Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S, Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J
Journal of general internal medicine
Authors: Cho HJ, Wray CM, Maione S, Macharet F, Bansal A, Lacy ME, Tsega S